Stock listing

BCDA Stock Price, News, Filings & Events — Biocardia, Inc.

Selected listing: BCDA · NASDAQ · USD · US

This page tracks Biocardia, Inc.'s BCDA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BCDA:NASDAQ. BCDA:NASDAQ is the stock-level entry point for investors researching Biocardia, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biocardia, Inc. is a public company traded under the ticker BCDA in the American market. The company has a market capitalization of approximately $12.65 million. Biocardia focuses on developing innovative therapies for cardiovascular diseases.

BCDA:NASDAQUSDUSUpdated August 28, 2026
Biocardia, Inc. logo
Ticker
BCDA:NASDAQ
Asset type
Stock
Market cap
$17.4M
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

Biocardia, Inc. BCDA:NASDAQ stock context

This page tracks Biocardia, Inc.'s BCDA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BCDA:NASDAQ. BCDA:NASDAQ is the stock-level entry point for investors researching Biocardia, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biocardia, Inc. is a public company traded under the ticker BCDA in the American market. The company has a market capitalization of approximately $12.65 million. Biocardia focuses on developing innovative therapies for cardiovascular diseases.

Latest news from Biocardia, Inc.

All Biocardia, Inc. news →

Biocardia, Inc. earnings calls

Research Biocardia, Inc.

Alternate listings